We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1999:HKEXMan Wah Holdings Limited Analysis

Data as of 2026-03-17 - not real-time

HK$4.50

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Man Wah Holdings trades around HK$4.5, comfortably above its 20‑day SMA of ~4.76 but below the 50‑day SMA, indicating a short‑term pullback. The RSI sits near 38, suggesting the stock is not yet oversold, while the MACD histogram is negative, pointing to bearish momentum. Despite a modest revenue decline of about 3%, the company maintains solid gross (≈41%) and operating margins (≈18%) and generates strong operating cash flow exceeding HK$3.4 bn. Valuation metrics are attractive, with a trailing P/E near 8.5 and a P/B of 1.28, well below the sector average, and a dividend yield of roughly 6.7% supported by a payout ratio just over 50%. The DCF model, however, flags a fair value of HK$2.5, implying the market price is premium to intrinsic estimates, yet analyst consensus targets suggest upside of about 24% to HK$5.5.
The stock exhibits low systematic risk (beta ≈0.34) and moderate 30‑day volatility (~35%), but its consumer‑cyclical exposure and heavy reliance on the Chinese market introduce medium sector and geographic risk. Liquidity appears solid with stable trading volumes, and currency risk is moderate given diversified revenue streams. Overall, the fundamentals and dividend profile support a value‑oriented stance, while technical signals caution against immediate upside, leading to a hold recommendation in the short run and a buy outlook for medium to long horizons.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram indicating downward momentum
  • Price trading below short‑term SMA levels
  • RSI near 38 suggesting limited upside in the near term

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Analyst target price around HK$5.5 implies ~24% upside
  • Attractive dividend yield with sustainable payout
  • Strong cash flow generation supporting earnings growth

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Low beta and stable cash flows provide defensive qualities
  • Value‑oriented valuation metrics (low P/E, P/B) suggest upside potential
  • Diversified geographic footprint mitigates single‑market concentration

Key Metrics & Analysis

Financial Health

Revenue Growth-3.10%
Profit Margin12.43%
P/E Ratio8.5
ROE15.24%
ROA9.20%
Debt/Equity28.07
P/B Ratio1.3
Op. Cash FlowHK$3.4B
Free Cash FlowHK$721.4M

Technical Analysis

TrendNeutral
RSI38.1
SupportHK$4.45
ResistanceHK$5.20
MA 20HK$4.76
MA 50HK$4.76
MA 200HK$4.60
MACDBearish
VolumeStable
Fear & Greed Index79.45

Valuation

Fair ValueHK$2.49
Target PriceHK$5.60
Upside/Downside24.40%
GradeFair
TypeValue
Dividend Yield6.67%

Risk Assessment

Beta0.34
Volatility34.58%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.